GenomesDAO Raises Undisclosed Amount to Accelerate DTC Efforts and Develop Virtual Labs for Secure Monetization of Genomic Data
GenomesDAO, a biotech company based in London, has secured new funding from investors including Pantera Capital and Modular Capital. The amount of funding raised has not been disclosed. The company plans to use the funds to expand its direct-to-consumer efforts and develop its virtual labs. GenomesDAO offers a secure DNA data storage and sharing application called Genomes.io, which allows individuals to sequence, store, and monetize their genomic data while also providing biotech and pharmaceutical companies with access to genomic data for research and development purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Dominance Nears Peak Amid Bearish Divergence
Top 5 Decentralized Protocols: Unparalleled Innovations in the Crypto Space
Justin Sun Announces Major Update for Tron (TRX)
Tron (TRX) founder Justin Sun signaled an important change for the altcoin in his statement.
Warren Buffett’s Crypto Gift from Justin Sun Surges 1,000% in Value by 2024